This narrative review looks at whether changing gut bacteria, such as using probiotics, could help prevent or treat heat stroke. The article notes that much of the available evidence comes from preclinical studies and animal experiments. Strong clinical confirmation in humans is still limited. Most supporting data for probiotics are derived from animal experiments, which means results may not directly apply to people. The review provides useful insights for the prevention and treatment of heat stroke in clinical practice, but readers should interpret protective effects in humans carefully. Safety concerns were not reported in the review, and no specific adverse events were mentioned. Because the data relies heavily on non-human research, the main reason to be careful is that human trials are needed before these methods become standard care. Readers should take from this that the idea is promising but unproven in people. More research is required to confirm if these gut bacteria changes truly work for humans facing heat stroke risks.
Gut microbiota modulation offers insights for heat stroke prevention and treatment in clinical practiceGut bacteria may help prevent heat stroke, but human proof is limited
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This narrative review explores the role of gut microbiota modulation, specifically probiotics, in the context of heat stroke. The scope includes a synthesis of available literature to provide useful insights for prevention and treatment strategies in clinical practice. The authors highlight that most supporting data for probiotics are derived from animal experiments rather than human trials. Consequently, strong clinical confirmation is still limited within the current body of evidence. The review aims to bridge the gap between preclinical findings and practical application for clinicians managing heat stroke cases. However, the authors emphasize that much of the available evidence originates from preclinical studies. This distinction is critical when considering the translation of these findings to human patients. The review concludes that while the concept is promising, the data currently supports providing useful insights rather than definitive treatment protocols. Clinicians should interpret potential protective effects in humans carefully given the reliance on non-human data. The lack of robust human trials means that practice recommendations must remain cautious until further clinical confirmation is established.